130 related articles for article (PubMed ID: 1992043)
1. Iodine-125-MIBG therapy for neuroblastoma.
Hoefnagel CA; Smets L; Voûte PA; de Kraku J
J Nucl Med; 1991 Feb; 32(2):361-2. PubMed ID: 1992043
[No Abstract] [Full Text] [Related]
2. Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.
Sisson JC; Shapiro B; Hutchinson RJ; Zasadny KR; Mallette S; Mudgett EE; Wieland DM
J Nucl Biol Med (1991); 1991; 35(4):255-9. PubMed ID: 1823830
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric models and S factors for radiation doses to the bladder wall in children receiving therapeutic iodine-131-MIBG.
Bolster AA; Hilditch TE; Wheldon TE
J Nucl Med; 1995 Aug; 36(8):1530-1. PubMed ID: 7629603
[No Abstract] [Full Text] [Related]
4. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic implications of the uptake of radiolabelled mIBG for the treatment of neuroblastoma.
O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
Prog Clin Biol Res; 1991; 366():455-61. PubMed ID: 2068160
[No Abstract] [Full Text] [Related]
6. [131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma.
Hoefnagel CA; Voûte PA; De Kraker J; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):202-6. PubMed ID: 1823819
[TBL] [Abstract][Full Text] [Related]
7. Session on the treatment of neuroblastoma with radioiodinated metaiodobenzylguanidine. Chairmen's report.
Mastrangelo R; Voûte PA
J Nucl Biol Med (1991); 1991; 35(4):260-2. PubMed ID: 1823831
[No Abstract] [Full Text] [Related]
8. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").
Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828
[TBL] [Abstract][Full Text] [Related]
9. Session on the biology and treatment of neuroblastoma as related to metaiodobenzylguanidine. Chairmen's report.
Sisson JC; De Bernardi B
J Nucl Biol Med (1991); 1991; 35(4):199-201. PubMed ID: 1823818
[No Abstract] [Full Text] [Related]
10. Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidine.
Klingebiel T; Bruchelt G; Kaleva N; Wollmann H; Handgretinger R; Treuner J; Gupta D; Niethammer D
Prog Clin Biol Res; 1991; 366():509-12. PubMed ID: 2068167
[No Abstract] [Full Text] [Related]
11. Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma.
Hutchinson RJ; Sisson JC; Miser JS; Zasadny KR; Normolle DP; Shulkin BL; Francis IR; Wieland DM; Shapiro B
J Nucl Biol Med (1991); 1991; 35(4):237-40. PubMed ID: 1823826
[TBL] [Abstract][Full Text] [Related]
12. The use of [131I]metaiodobenzylguanidine in the treatment of neuroblastoma after conventional therapy.
Troncone L; Rufini V; Riccardi R; Lasorella A; Mastrangelo R
J Nucl Biol Med (1991); 1991; 35(4):232-6. PubMed ID: 1823825
[TBL] [Abstract][Full Text] [Related]
13. Experience with palliative [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
Castellani MR; Rottoli L; Maffioli L; Massimino M; Gasparini M; Buraggi GL
J Nucl Biol Med (1991); 1991; 35(4):241-3. PubMed ID: 1726677
[TBL] [Abstract][Full Text] [Related]
14. A human neuroblastoma xenograft model for [131I]-metaiodobenzylguanidine (MIBG) biodistribution and targeted radiotherapy.
Rutgers M; Gubbels AA; Hoefnagel CA; Voûte PA; Smets LA
Prog Clin Biol Res; 1991; 366():471-8. PubMed ID: 2068162
[No Abstract] [Full Text] [Related]
15. Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. "Société Française d'Oncologie Pédiatrique" and Nuclear Medicine Co-investigators.
Lumbroso J; Hartmann O; Schlumberger M
J Nucl Biol Med (1991); 1991; 35(4):220-3. PubMed ID: 1823822
[TBL] [Abstract][Full Text] [Related]
16. Model studies on metaiodobenzylguanidine (MIBG) uptake and storage: relevance for 131I-MIBG therapy of neuroblastoma.
Smets LA; Rutgers M
J Nucl Biol Med (1991); 1991; 35(4):191-4. PubMed ID: 1823816
[No Abstract] [Full Text] [Related]
17. [Iodobenzylguanide-131 therapy as first choice in non-metastasized neuroblastoma].
De Kraker J; Hoefnagel CA; Caron HN; Vos A; Bras J; Greve JC
Ned Tijdschr Geneeskd; 1996 Oct; 140(40):1997-2000. PubMed ID: 8965930
[TBL] [Abstract][Full Text] [Related]
18. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
19. Radiolabelled mIBG in the treatment of neuroblastoma.
Gaze MN; Wheldon TE
Eur J Cancer; 1996 Jan; 32A(1):93-6. PubMed ID: 8695251
[No Abstract] [Full Text] [Related]
20. Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy.
Voûte PA; Hoefnagel CA; de Kraker J; Valdes Olmos R; Bakker DJ; van de Kleij AJ
Prog Clin Biol Res; 1991; 366():439-45. PubMed ID: 2068157
[No Abstract] [Full Text] [Related]
[Next] [New Search]